Table 2.
Geriatric assessment domains.
Measure | Median (Range) | Geriatric impairment identified n (%) | Resulting in MDT Change |
---|---|---|---|
Instrumental Activities of Daily Living (IADL) | 14 [[7], [8], [9], [10], [11], [12], [13], [14]] | 25 (24.8%) | 9/25 |
Medical Outcomes Study (MOS) Activities of Daily Living (ADL) | 75 (0–100) | 67 (66.3%) | 20/67 |
Karnofsky Performance Status Scale (self-reported) | 90 (50–100) | 21 (20.8%) | 9/21 |
Karnofsky Performance Status Scale (Physician reported) | 90 (50–100) | 21 (20.8%) | 9/21 |
Comorbidity: Physical Health Section (Older American Resources & Services Questionnaire (OARS) (>2) | 3 (0–8) | 53 (52.5%) | 15/53 |
Polypharmacya | 4 (0–17) | 60 (65.3%) | 20/60 |
Falls in last 6 monthsb | 9 (8.9%) | 4/9 | |
Unintentional weight loss | 0 (0–25 kg) | 10 (9.9%) | 3/10 |
BMI (30 or more) | 29 (19–53.7) | 37 (39.8%) | 12/37 |
Psychological Status: Mental Health Inventory (MHI)-17 | 79 (38–93) | 5 (5%) | 1/5 |
Social Functioning: Medical Outcomes Study (MOS) Social Activity Limitations Measure | 58.33 (0–100) | 30 (29.7%) | 9/30 |
Social Support: Medical Outcomes Study (MOS) Social Support Survey | 100 (0–100) | 8 (7.9%) | 5/8 |
Depressionc | 21 (20.8%) | 5/21 | |
Timed Up and Go (sec) | 12 Sec (6–60) | 85 (84.2%) | 19/85 |
Blessed Orientation-Memory-Concentration Test | 2 (0–14) | 3 (3.0%) | 0/3 |
Polypharmacy (3 or more medications).
Falls in last 6 months: recorded as yes/no.
Depression: recorded as yes/no.